NCT07537621

Brief Summary

Preload responsiveness and venous congestion have largely been investigated independently in recent literature. However, recent data report a similar incidence of venous congestion regardless of fluid responsiveness status, challenging the concept of a linear continuum between preload independence and fluid intolerance. These findings support the need for a more individualized hemodynamic management strategy that takes venous congestion risk into account. The right ventricle plays a central role in this framework. Its function is to maintain an adequate venous return pressure gradient to ensure cardiac output while limiting upstream venous congestion, under strong dependence on its afterload. In physiological conditions, the right ventricle adapts to changes in afterload by increasing contractility to preserve right ventriculo-arterial coupling and optimize its performance. In chronic cardiopulmonary diseases, right ventriculo-arterial uncoupling is a well-established prognostic factor, including the presence of occult uncoupling revealed by fluid loading. In critically ill patients, right ventricular systolic dysfunction associated with venous congestion-defining right heart failure-is strongly associated with increased mortality, as is right ventriculo-arterial uncoupling itself. To support the concept of fluid tolerance, the investigators hypothesize that impairment of right ventriculo-arterial coupling may exist or occur during fluid loading in critically ill patients, independently of preload responsiveness, and may be associated with worsening upstream venous congestion.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
37mo left

Started May 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026May 2029

First Submitted

Initial submission to the registry

April 8, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2029

Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

3 years

First QC Date

April 8, 2026

Last Update Submit

April 16, 2026

Conditions

Keywords

Right ventriculo-arterial couplingFluid loadingVenous congestionVEXUS scoreCritical care echocardiography

Outcome Measures

Primary Outcomes (2)

  • Right Ventriculo-Arterial Coupling Changes During Fluid Loading

    Echocardiographic assessment of right ventriculo-arterial coupling will be performed using the TAPSE/TRV ratio before and after fluid loading. The primary outcome is the change in TAPSE/TRV, reflecting alterations in right ventricular contractility and coupling with the pulmonary circulation in response to fluid administration. This outcome will be used to evaluate the prevalence and dynamics of RV uncoupling in critically ill patients.

    Before a fluid loading procedure (approximately 30 min)

  • Right Ventriculo-Arterial Coupling Changes During Fluid Loading

    Echocardiographic assessment of right ventriculo-arterial coupling will be performed using the TAPSE/TRV ratio before and after fluid loading. The primary outcome is the change in TAPSE/TRV, reflecting alterations in right ventricular contractility and coupling with the pulmonary circulation in response to fluid administration. This outcome will be used to evaluate the prevalence and dynamics of RV uncoupling in critically ill patients.

    after a fluid loading procedure (approximately 30 min)

Secondary Outcomes (11)

  • Variation of Right Ventriculo-Arterial Coupling According to Fluid Responsiveness

    Before a single fluid loading episode

  • Variation of Right Ventriculo-Arterial Coupling According to Fluid Responsiveness

    after a single fluid loading episode

  • Association Between Right Ventriculo-Arterial Coupling and Venous Congestion

    Before fluid loading

  • Association Between Right Ventriculo-Arterial Coupling and Venous Congestion

    after fluid loading

  • Predictors of Right Ventriculo-Arterial Coupling Deterioration

    before fluid loading

  • +6 more secondary outcomes

Study Arms (1)

Critically Ill Patients Receiving Fluid Loading

The study group consists of adult critically ill patients admitted to the intensive care unit who undergo fluid loading as part of routine clinical care, at the discretion of the attending physician. All patients are prospectively and consecutively included in a single observational cohort. Echocardiographic assessment of right ventricular function, right ventriculo-arterial coupling, and venous congestion parameters is performed before and after fluid administration. The group will be analyzed as a whole, with secondary analyses stratifying patients according to fluid responsiveness or presence of venous congestion. This cohort reflects standard clinical practice in critically ill patients with acute circulatory failure.

Other: Echography

Interventions

Fluid loading administered according to standard clinical practice at the discretion of the treating physician. Echocardiographic assessment of right ventricular function and venous congestion is performed before and after fluid administration. No experimental treatment is applied.

Critically Ill Patients Receiving Fluid Loading

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult critically ill patients with acute circulatory failure. Eligible patients are those for whom the attending physician independently decides to perform fluid loading as part of standard care, in accordance with current European recommendations. Patients may present with hypotension requiring vasopressor support, low mean arterial pressure, or other signs of hemodynamic instability. Participants are prospectively and consecutively included at the time of fluid loading decision, and undergo standardized echocardiographic assessment of right ventricular function and venous congestion before and after fluid administration. The population reflects routine clinical practice in the intensive care unit.

You may qualify if:

  • Critically ill hospitalized patients
  • Age ≥ 18 years
  • Patients undergoing fluid loading at the discretion of the attending physician, following prediction of fluid responsiveness using any recommended maneuver or dynamic parameter, in the setting of acute circulatory failure requiring vasopressor support and/or mean arterial pressure \< 65 mmHg (or a decrease of ≥ 30 mmHg from baseline in patients with chronic hypertension), and/or other signs of hemodynamic instability (tachycardia, mottling, oliguria, hyperlactatemia)
  • Affiliated with a national health insurance system

You may not qualify if:

  • Formal refusal from the patient or legally representative after information
  • Patients transferred from another intensive care unit
  • Pregnant or postpartum patients
  • Acute respiratory distress (defined as respiratory rate ≥ 35 breaths/min and/or signs of increased work of breathing)
  • Ongoing acute coronary syndrome
  • Acute or pulmonale (defined by right ventricular dilation associated with paradoxical septal motion related to an abrupt increase in right ventricular afterload)
  • Primary pulmonary arterial hypertension
  • Intra-abdominal hypertension (intravesical pressure \> 15 mmHg)
  • Poor echogenicity precluding adequate echocardiographic assessment of the right ventricle
  • Severe valvular heart disease or early postoperative period following valvular surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marie Muller

Reims, France

Location

MeSH Terms

Conditions

ShockVentricular Dysfunction, RightHyperemia

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsVentricular DysfunctionHeart DiseasesCardiovascular DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Central Study Contacts

Guillaume THERY

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2026

First Posted

April 17, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

May 1, 2029

Last Updated

April 17, 2026

Record last verified: 2026-04

Locations